– Company speakers include Doug Drysdale, Chief Executive Officer; and Amir Inamdar, MBBS, DNB (Psych), MFPM, Chief Medical Officer – – Featured key opinion leaders include Dr. Maurizio Fava, M.D., Massachusetts General Hospital and Harvard Medical School; and Dr. Gitte Moos Knudsen, Professor, Chief Neurologist, DMSc, Neurobiology Research Unit, Rigshospitalet and University of Copenhagen, Denmark…
Hepatitis B market is ripe for treatment development, says Aligos CEO – Pharmaceutical Technology
As the hepatitis virus infectious burden remains an issue, Aligos Therapeutics CEO highlights the opportunity for pharmaceutical companies to find success by offering new treatment